⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

Official Title: Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

Study ID: NCT05337631

Interventions

Study Description

Brief Summary: The number of elderly head-and-neck squamous cell carcinoma (HNSCC) patients is increasing; however, the evidence regarding the ideal treatment for this often vulnerable and frail patient cohort is limited. Although the benefit of concomitant chemotherapy has been reported to decrease in elderly HNSCC patients based on the MACH-NC meta-analysis, it remains unknown whether state-of-the art radiotherapy techniques such as intensity-modulated radiotherapy (IMRT), modern supportive treatments and alternative chemotherapy fractionation (e.g., cisplatin weekly) may have altered this observation. The objective of this retrospective multinational multicenter study is to determine the oncological outcomes of elderly patients (≥65 years) with locally advanced HNSCCs undergoing definitive (chemo-)radiation and to investigate the influence of concomitant chemotherapy on overall survival and progression-free survival after adjusting for potential confounder variables such as age, performance status and comorbidity burden.

Detailed Description:

Eligibility

Minimum Age: 65 Years

Eligible Ages: OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, United States

Department of Radiation Oncology, Case Western Reserve University, Cleveland, Ohio, United States

Division of Radiation Oncology, The Ohio State University Wexner, Columbus, Ohio, United States

Radiation Oncology Department, German Oncology Center, Limassol, , Cyprus

Department of Radiooncology and Radiotherapy, Charité-Universitätsmedizin Berlin, Berlin, , Germany

Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, , Germany

Department of Radiotherapy and Oncology, Goethe-University Frankfurt am Main, Frankfurt, , Germany

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, , Germany

Department of Radiation Oncology, University Medical Center Leipzig, Leipzig, , Germany

Department of Radiation Oncology, University Medical Center Mainz, Mainz, , Germany

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, , Germany

Department of Radiation Oncology, University Hospital Würzburg, Würzburg, , Germany

Department of Radiation Oncology, University Hospital Zurich (USZ), University of Zurich (UZH), Zürich, , Switzerland

Contact Details

Name: Nils H. Nicolay, MD, PhD

Affiliation: Department of Radiation Oncology, Medical Center - University of Freiburg

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: